Get started
Author

Kaiqing Li

Clinical advances and challenges associated with TCR-T cell therapy for cancer treatment
2024 · Jianing Li, Yongsheng Zhang, et al. · Frontiers in Immunology · 27
PDF
Possible correlated signaling pathways with chronic urate nephropathy: A review
2023 · Kaiqing Li, Yanchun Ma, et al. · Medicine · 13
Progress in animal models for studying hyperuricemia
2025 · Senyue Zhang, Kaiqing Li, et al. · Frontiers in Pharmacology · 11
PDF
Research progress on the mechanism of hyperuricemic nephropathy based on multi-omics technique: A review
2024 · Kaiqing Li, Xue Xia, et al. · Medicine · 9
Treatment of Parkinson disease by acupuncture combined with medicine based on syndrome differentiation from the perspective of modern medicine: A review
2023 · Xue Xia, Xu Dong, et al. · Medicine · 6
Advances in the Use of Immune Checkpoint Inhibitors for Colorectal Cancer Treatment
2025 · Jianing Li, Tong Fu, et al. · OncoTargets and Therapy · 5
PDF
Comprehensive Treatment of Gout with Traditional Chinese Medicine: A Modern Pathophysiological Perspective
2025 · Jiamin Yang, Rui Xu, et al. · International Journal of General Medicine · 4
PDF
Network Pharmacology and Transcriptomic Analysis Reveal the Therapeutic Mechanisms of Xiebai Bining Decoction in Hyperuricemic Nephropathy
2026 · Jianing li, Xuejie Zhu, et al. · Combinatorial Chemistry & High Throughput Screening · 1
Xiebai bining decoction attenuates renal fibrosis in hyperuricemic nephropathy alongside changes in FUNDC1/LC3B autophagy markers and TGF-β1/Smad3 signaling
2026 · Kaiqing Li, Xue Xia, et al. · Frontiers in Cell and Developmental Biology
PDF
Commentary on “Apabetalone, a BET protein inhibitor, inhibits kidney damage in diabetes by preventing pyroptosis via modulating the P300/H3K27ac/PLK1 axis”
2024 · Kaiqing Li, Xue Xia, et al. · Pharmacological Research
Works count: 10
Citation count: 76
H-index: 5
I10-index: 3
Year
Topic
Type